Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$49.79 - $68.85 $1.47 Million - $2.03 Million
-29,500 Reduced 29.65%
70,000 $4.79 Million
Q1 2024

May 15, 2024

BUY
$51.15 - $56.52 $823,515 - $909,972
16,100 Added 19.3%
99,500 $5.34 Million
Q4 2023

Feb 14, 2024

BUY
$43.79 - $55.14 $3.13 Million - $3.94 Million
71,400 Added 595.0%
83,400 $4.44 Million
Q3 2023

Nov 14, 2023

SELL
$49.1 - $62.37 $3.41 Million - $4.33 Million
-69,400 Reduced 85.26%
12,000 $595,000
Q2 2023

Aug 14, 2023

SELL
$52.61 - $59.54 $1.05 Million - $1.19 Million
-20,000 Reduced 19.72%
81,400 $4.85 Million
Q1 2023

May 15, 2023

BUY
$51.83 - $79.63 $1.76 Million - $2.71 Million
34,000 Added 50.45%
101,400 $5.74 Million
Q4 2022

Feb 14, 2023

BUY
$58.4 - $75.53 $1.94 Million - $2.51 Million
33,200 Added 97.08%
67,400 $5.01 Million
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $304,260 - $371,470
5,500 Added 19.16%
34,200 $2.04 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.44B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.